Gaudium IVF and Women Health Ltd.
Price Range
₹75–79
Issue Size
₹ 116 Cr
Lot Size
189 Shares
Min. Investment
₹ 14,175
Financial Summary
(in crores)| Particulars | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Operating Revenue | 7,072.4 | 4,789.01 |
| Other Income | 23.44 | 26.3 |
| Total Income | 7,095.84 | 4,815.31 |
| Total Expenses | 4,184.51 | 2,845.06 |
| Profit Before Tax | 2,542.25 | 1,663.16 |
| Total Profit | 1,912.74 | 1,031.69 |
Subscription Details
Subscription
IPO Timeline
IPO Offer Start
20 Feb 2026
IPO Offer Ends
24 Feb 2026
Listing Date
27 Feb 2026
Use of Proceeds
| # | Purpose | Amount (₹ Cr) |
|---|---|---|
| 1 | Funding capital expenditure towards establishment of New IVF Centers of our Company | 500 |
| 2 | Repayment/pre-payment, in full or in part, of certain outstanding loans availed by our Company | 200 |
Promoters
Promoter Shareholding
Pre-IPO
99.98%
Promoter stake
Post-IPO
71.29%
Promoter stake
Offered to Public
2,08,86,200
shares
Post Share Capital
5,18,91,384
shares
About the Company
Parenthood is a joyful journey, especially for mothers who experiences motherhood. We understand the challenges couples face in building a family due to infertility, medical issues, or lifestyle factors. Our mission is to help make their dream of parenthood come true through personalized fertility treatments. From the first consultation to a successful pregnancy, we provide expert care, support, and a close partnership with our patients, ensuring a hopeful and joyful future.
Use of Proceeds
1) Funding capital expenditure towards establishment of New IVF Centers of our Company. 2) Repayment/pre-payment, in full or in part, of certain outstanding loans availed by our Company. 3) General Corporate Purposes.